Pressure BioSciences Hires IssuWorks to Explore Strategic Alternatives | GenomeWeb

NEW YORK (GenomeWeb) – Pressure BioSciences said on Thursday that it has engaged investment bank IssuWorks to review strategic and financing alternatives, including the potential spin off of "vertical market applications into new, stand-alone businesses."

In a statement, Pressure Bio CEO Richard Schumacher said that with the help of IssuWorks, "we will immediately begin to look at various … alternatives that we believe have the potential to result in the generation of increased value for all shareholders of" the company.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: genetic study of breast cancer in Egyptian families, mutations linked to cleft lip and palate, and more.

Council Bluffs, Iowa, schools are encouraging more girls to pursue STEM courses, according to the Associated Press.

Because of new open-access requirements, Gates Foundation-funded researchers can't publish in some top journals, Nature News reports.

In Science this week: deletion of one microRNA allows pluripotent stem cells to form embryonic and non-embryonic lineages, and more.

Mar
02
Sponsored by
VelaDx

This online seminar will highlight recent advances in the use of next-generation sequencing to detect drug-resistant mutations in patients with HIV or HCV.